The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Plooster Matthew R since 2022.
This trader's CIK number is 1638364.
At the time of last reporting, Plooster Matthew R was the Director of Zevra Therapeutics, Inc.. (stock ticker symbol ZVRA).
Also see all insider trading activities at Zevra Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ZVRA | 11,000 | $46,145 | 0 | $0 | 0 | $0 |
| 2022 | ZVRA | 5,000 | $24,775 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-09 | ZVRA | Buy | 11,000 | 4.20 | 46,145 |
| 2022-05-18 | KMPH | Buy | 5,000 | 4.96 | 24,775 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Plooster Matthew R (Director of Zevra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.